This Article Full Text Full Text (PDF) Supplementary Data All Versions of this Article: 0008-5472.CAN-08-4147v1 69/15/6092    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Bousquet, E. Articles by Pradines, A. PubMed PubMed Citation Articles by Bousquet, E. Articles by Pradines, A.

Loss of RhoB Expression Promotes Migration and Invasion of Human Bronchial Cells Via Activation of AKT1

¹ Institut National de la Sante et de la Recherche Medicale U563-Département Innovation Thérapeutique et Oncologie Moléculaire; ² Université de Toulouse, UPS, Centre de Physiopathologie Toulouse Purpan; ³ Institut Claudius Regaud, Département de Biologie; ⁴ CHU Toulouse, Service de Pneumologie, Hôpital Larrey, Toulouse, France

Requests for reprints: Anne Pradines, Institut Claudius Regaud, 20-24 rue du Pont Saint Pierre, 31052 Toulouse Cedex, France. Phone: 33-5-61-42-42-26; Fax: 33-5-61-42-46-31; E-mail: pradines.anne{at}claudiusregaud.fr.

Key Words: RhoB • invasion • migration • lung cancer • AKT

Lung cancer is the leading cause of cancer-related death worldwide, mainly due to its highly metastatic properties. Previously, we reported an inverse correlation between RhoB expression and the progression of the lung cancer, occurring between preinvasive and invasive tumors. Herein, we mimicked the loss of RhoB observed throughout lung oncogenesis with RNA interference in nontumoral bronchial cell lines and analyzed the consequences on both cell transformation and invasion. Down-regulation of RhoB did not modify the cell growth properties but did promote migration and invasiveness. Furthermore, RhoB depletion was accompanied by modifications of actin and cell adhesion. The specific activation of the Akt1 isoform and Rac1 was found to be critical for this RhoB-mediated regulation of migration. Lastly, we showed that RhoB down-regulation consecutive to K-RasV12 cell transformation is critical for cell motility but not for cell proliferation. We propose that RhoB loss during lung cancer progression relates to the acquisition of invasiveness mediated by the phosphatidylinositol 3-kinase (PI3K)/AKT and Rac1 pathways rather than to tumor initiation. [Cancer Res 2009;69(15):6092–99]